Literature DB >> 9472652

The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia.

V Bataille1, A Grulich, P Sasieni, A Swerdlow, J Newton Bishop, W McCarthy, P Hersey, J Cuzick.   

Abstract

Two case-control studies were set up to investigate the relationship between melanocytic naevi and risk of melanoma and to compare the naevus phenotype in two countries exposed to greatly different levels of sun exposure and different melanoma rates. In England 117 melanoma cases and 163 controls were recruited from the North-East Thames Region and 183 melanoma cases and 162 controls from New South Wales, Australia. Each subject underwent a whole-body naevus count performed by the same examiner in each country. Relative risks associated with melanocytic naevi in each country were calculated with comparison of naevus data in controls between Australia and England. Atypical naevi were strong risk factors for melanoma in both countries: the odds ratio (OR) for three or more atypical naevi was 4.6 (95% CI 2.0-10.7) in Australia compared with 51.7 (95% CI 6.5-408.4) in England. Common naevi were also significant risk factors in Australia and England with similar odds ratios in the two countries. Prevalence of atypical naevi was greater in Australian controls than in English controls: OR 9.7 (95% CI 1.2-81.7) for three or more atypical naevi in Australia compared with England. For young age groups, the median number of common naevi was greater in Australia than in the UK, whereas for older individuals this difference in naevi number between the two countries disappeared. The prevalence of naevi on non-sun-exposed sites in controls was not significantly different between the two countries. The atypical mole syndrome (AMS) phenotype was more prevalent in Australian controls (6%) than in English controls (2%). The results of this study support the role of sun exposure in the induction of atypical naevi in adults. There was a trend towards stronger risk factors associated with atypical naevi in England compared with Australia. The atypical mole syndrome, usually associated with a genetic susceptibility to melanoma, was more common in Australia than in England, suggesting genetic environmental interactions with the possibility of phenocopies induced by sunlight.

Entities:  

Mesh:

Year:  1998        PMID: 9472652      PMCID: PMC2151302          DOI: 10.1038/bjc.1998.81

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  Benign melanocytic naevi as a risk factor for malignant melanoma.

Authors:  A J Swerdlow; J English; R M MacKie; C J O'Doherty; J A Hunter; J Clark; D J Hole
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-14

2.  Risk factors for cutaneous melanoma in Queensland.

Authors:  A Green; C Bain; R McLennan; V Siskind
Journal:  Recent Results Cancer Res       Date:  1986

3.  Development and elimination of pigmented moles, and the anatomical distribution of primary malignant melanoma.

Authors:  E M Nicholls
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

4.  Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia.

Authors:  A E Grulich; V Bataille; A J Swerdlow; J A Newton-Bishop; J Cuzick; P Hersey; W H McCarthy
Journal:  Int J Cancer       Date:  1996-08-07       Impact factor: 7.396

5.  High risk of malignant melanoma in melanoma-prone families with dysplastic nevi.

Authors:  M H Greene; W H Clark; M A Tucker; K H Kraemer; D E Elder; M C Fraser
Journal:  Ann Intern Med       Date:  1985-04       Impact factor: 25.391

6.  Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types.

Authors:  C D Holman; B K Armstrong
Journal:  J Natl Cancer Inst       Date:  1984-07       Impact factor: 13.506

7.  Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma.

Authors:  C D Holman; B K Armstrong
Journal:  J Natl Cancer Inst       Date:  1984-02       Impact factor: 13.506

8.  Etiology of common acquired melanocytic nevi: constitutional variables, sun exposure, and diet.

Authors:  B K Armstrong; N H de Klerk; C D Holman
Journal:  J Natl Cancer Inst       Date:  1986-08       Impact factor: 13.506

9.  Frequency of moles in a defined population.

Authors:  K R Cooke; G F Spears; D C Skegg
Journal:  J Epidemiol Community Health       Date:  1985-03       Impact factor: 3.710

10.  The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population.

Authors:  R M MacKie; J English; T C Aitchison; C P Fitzsimons; P Wilson
Journal:  Br J Dermatol       Date:  1985-08       Impact factor: 9.302

View more
  22 in total

1.  Cigarette smoking and malignant melanoma: a case-control study.

Authors:  Maria C Kessides; Lee Wheless; Judith Hoffman-Bolton; Sandra Clipp; Rhoda M Alani; Anthony J Alberg
Journal:  J Am Acad Dermatol       Date:  2010-03-23       Impact factor: 11.527

2.  Nevus count associations with pigmentary phenotype, histopathological melanoma characteristics and survival from melanoma.

Authors:  Nicholas J Taylor; Nancy E Thomas; Hoda Anton-Culver; Bruce K Armstrong; Colin B Begg; Klaus J Busam; Anne E Cust; Terence Dwyer; Lynn From; Richard P Gallagher; Stephen B Gruber; Diane E Nishri; Irene Orlow; Stefano Rosso; Alison J Venn; Roberto Zanetti; Marianne Berwick; Peter A Kanetsky
Journal:  Int J Cancer       Date:  2016-05-30       Impact factor: 7.396

3.  Cross-sectional analysis of the dermoscopic patterns and structures of melanocytic naevi on the back and legs of adolescents.

Authors:  M Fonseca; M A Marchetti; E Chung; S W Dusza; M E Burnett; A A Marghoob; A C Geller; M Bishop; A Scope; A C Halpern
Journal:  Br J Dermatol       Date:  2015-10-27       Impact factor: 9.302

Review 4.  Melanocytic Nevi and the Genetic and Epigenetic Control of Oncogene-Induced Senescence.

Authors:  Jennifer M Huang; Ijeuru Chikeka; Thomas J Hornyak
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

5.  The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects.

Authors:  Keith Duffy; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2012-07       Impact factor: 11.527

Review 6.  Malignant melanoma (non-metastatic): sentinel lymph node biopsy.

Authors:  Andy Pay
Journal:  BMJ Clin Evid       Date:  2016-01-19

Review 7.  Malignant melanoma (metastatic).

Authors:  Rosalie Anne Fisher; James Larkin
Journal:  BMJ Clin Evid       Date:  2010-12-21

Review 8.  Malignant melanoma (metastatic).

Authors:  James Larkin; Martin Gore
Journal:  BMJ Clin Evid       Date:  2008-08-22

Review 9.  Malignant melanoma (non-metastatic).

Authors:  Philip Savage
Journal:  BMJ Clin Evid       Date:  2007-06-01

10.  A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes.

Authors:  Yu-mei Chang; Julia A Newton-Bishop; D Timothy Bishop; Bruce K Armstrong; Veronique Bataille; Wilma Bergman; Marianne Berwick; Paige M Bracci; J Mark Elwood; Marc S Ernstoff; Adèle C Green; Nelleke A Gruis; Elizabeth A Holly; Christian Ingvar; Peter A Kanetsky; Margaret R Karagas; Loïc Le Marchand; Rona M Mackie; Håkan Olsson; Anne Østerlind; Timothy R Rebbeck; Kristian Reich; Peter Sasieni; Victor Siskind; Anthony J Swerdlow; Linda Titus-Ernstoff; Michael S Zens; Andreas Ziegler; Jennifer H Barrett
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.